Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy
- 1 January 2008
- journal article
- clinical trial
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 99 (11) , 930-935
- https://doi.org/10.1160/th08-01-0002
Abstract
Summary: A high platelet turnover rate produce a population of immature reticulated platelets (RP) that could confer, despite of antiplatelet drugs, a residual platelet reactivity (RPR) in coronary artery disease (CAD) patients. To assess the influence of RP on platelet reactivity in CAD patients on dual antiplatelet therapy we measured RP in 372 patients by using the Sysmex XE-2100 haematology analyzer and platelet function by optical platelet aggregometry (PA) on platelet-rich-plasma induced by 1 mmol arachidonic acid (AA-PA) and 10 μM ADP (ADP-PA). RPR was defined as either AA-PA >20% or ADP-PA >70%. RP were expressed as a percentage of RP of the total optical platelet count (immature platelet fraction; IPF) and as the percentage of RP highly fluorescent (higly fluorescent immature platelet fraction; H-IPF). Moderate but significant positive correlations between PA, IPF, H-IPF, and mean platelet volume (MPV) were found. According to tertiles of IPF, H-IPF and MPV, a significant trend for an increase of platelet aggregation by AA and ADP was evidenced. Furthermore, a significant difference for IPF, H-IPF and MPV between patients with and without RPR was observed. A linear regression analysis showed that IPF, H-IPF and MPV significantly affected PA measured by AA and ADP. At multivariate linear regression analysis these associations were confirmed. Moreover, a logistic regression analysis demonstrated that IPF, H-IPF and MPV significantly influenced the risk of RPR, and in the multivariate model these results remained significant. This study indicates that a high rate of platelet turnover is a new mechanism associated with platelet reactivity in high risk CAD patients on dual antiplatelet therapy.Keywords
This publication has 24 references indexed in Scilit:
- Reticulated platelets and uninhibited COX‐1 and COX‐2 decrease the antiplatelet effects of aspirinJournal of Thrombosis and Haemostasis, 2007
- ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndromeThrombosis and Haemostasis, 2007
- Usefulness of Aspirin Resistance After Percutaneous Coronary Intervention for Acute Myocardial Infarction in Predicting One-Year Major Adverse Coronary EventsThe American Journal of Cardiology, 2006
- High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndromeJournal of Thrombosis and Haemostasis, 2006
- Dose- and time-dependent antiplatelet effects of aspirinThrombosis and Haemostasis, 2006
- Reticulated platelets in acute coronary syndrome: A marker of platelet activityJournal of the American College of Cardiology, 2004
- A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular diseaseJournal of the American College of Cardiology, 2003
- Flow cytometric analysis of reticulated platelets in patients with ischemic strokeThrombosis Research, 2002
- The Significance of Platelets with Increased RNA Content (Reticulated Platelets) A Measure of the Rate of ThrombopoiesisAmerican Journal of Clinical Pathology, 1992
- Influence of platelet size on outcome after myocardial infarctionThe Lancet, 1991